SummaryUnlike older medications that target serotonin – a “feel-good” chemical in the brain – the ketamine-based nasal spray works on a different neurotransmitter called glutamate. Read on to know more.
SummaryWith FDA approval, Zevaskyn is set to be a game-changer in the treatment of recessive dystrophic epidermolysis bullosa—offering patients more than just relief, but a meaningful step toward healing.